|
HEBEI HUANWEI BIOTECH CO., LTD.
|
Specifications:
Identification: Positive
Particle Size(0.28MM Sieve): 90% pass through
Loss on dring: 3.0% max
Residue on ignition: 5% max
Volatilizable Impurity of Organic: Conform
Assay (on dry basis) (HPLC): 80% min
Apperrance: Yellow to Orange-yellow free flowing powder.
|
ITEM
|
STANDARD
|
|
Character
|
Yellow to Orange-yellow free flowing particle
|
|
Identification Positive
|
Must comply
|
|
Particle Size(0.28MM Sieve)
|
Sieve 90% pass through 0.28mm normal sieve
|
|
Loss on dring
|
3.0% max
|
|
Residue on ignition
|
5% max
|
|
Volatilizable Impurity of Organic
|
Msut comply
|
|
Assay(on dry material)
|
77.8-84%
|
|
Inspection method
|
According to “Feed additive-Riboflavin flowing particle”GB/T 18632-2002.
|
Packing: Normally in 25kg paper cartons with PE liners.
Storage: Stable powder, keep container closed in a dark, dry and cool condition when in not use
|
Send Inquiry
|
|
Benepure Pharmaceutical Co., Ltd.
|
Yellow or orange yellow crystalline powder; smells slightly bitter; Slightly dissolves in water, not dissolve in ether, alcohol and chloroform, with the melting point of 281∽290℃.BENEPURE.Riboflavin is the essential necessity for organism in normal living as the nutriment for infant, pregnant woman nursing mother, patient after illness and the aged. It, involve , participates in the metabolishm of carbonhydrate, protein and fat, and is the major composition of flavorprotein, the transferring enzyme system of hydrogen, In clinical practice, it is applicable to perleche, glossitis, ophthalmitis, conjunctivitis, ceborrhea, scrotum inflammations with proper effect ,In food and feed industry, it is widely used as food and feed additives.
|
Send Inquiry
|
|
Quanzhou Fortune Biopharma Co.,Ltd.
|
Vitamin B2, also called riboflavin, is one of 8 B vitamins. All B vitamins help the body to convert food (carbohydrates) into fuel (glucose), which is used to produce energy. These B vitamins, often referred to as B-complex vitamins, also help the body metabolize fats and protein.
|
Send Inquiry
|
Pharma Sources Insight January 2025
